For the third quarter of 2024, Ascendis Pharma reported a net loss of €99.2 million, or €1.72 per share (basic and diluted) ...

So, I’m sitting there watching a parade of commercials – interrupted from time to time by a football game – and I’m thinking … why do the beer and pharma companies spend so much on their little ...

Although incumbent Montana Sen. Jon Tester lost his race for U.S. Senate, that hasn’t stopped a barrage of attack ads running ...

Shares of Medicus Pharma tumbled 39%, to $2.50, on the company's first day of trading Thursday. The biotechnology and life-sciences pharmaceutical company on Wednesday said it would sell 970,000 units ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

BRS working president K T Rama Rao alleged that the police department is working like a private army of the Chief Minister to ...

It attributed the downturn to the July-August mass upsurge, labour unrest, and prolonged flooding, which significantly impacted operations and distribution channels.

Roughly a year ago, Gilead Sciences revealed that it was laying off about 7% of Kite Pharma’s workforce in a bid to refresh ...

The Wilmington International Airport and Frontier Scientific Solutions announced a new project utilizing the first free trade ...

On Wednesday, BridgeBio Pharma Inc (BBIO) stock saw a modest uptick, ending the day at $24.79 which represents a slight increase of $0.17 or 0.69% from the prior close of $24.62. The stock opened at ...

Nuvectis Pharma shares fell steeply after updated data from its early-stage study evaluating NXP800 to treat an aggressive type of ovarian cancer showed that a change in the dosing schedule only ...